These and other GLP1-RA diabetes/weight-loss meds can also boost outcomes for folks battling chronic kidney disease, new ...

Kidney disease, leading to kidney failure, afflicts disproportionately more black people than white people. Thus, there is a ...

A latest research led by Dr Shuyao Zhang, an assistant professor of internal medicine at UT Southwestern in Dallas reveal the ...

Duncan, who has chronic kidney disease, has worked with dance companies in Chicago and around the world over his decades-long ...

Learn how chronic kidney disease and diabetes accelerate heart risk, with new research revealing early warning signs.

Chronic kidney disease (CKD) is a progressive renal disease that causes kidney function to deteriorate. It appears as urinary ...

Over 1,000 genes may serve as possible treatment targets for individuals with kidney disease, according to a new study. By creating the most complete and detailed genetic 'map' of kidney function to ...

The Food and Drug Administration approved Novo Nordisk’s Ozempic as the first GLP-1 treatment option for people with type 2 ...

The FDA has approved Ozempic (semaglutide) to reduce the risk of kidney disease worsening and cardiovascular death in those with T2D and CKD.

Covenant Health in conjunction with the South Plains Kidney Foundation will host two sessions for medical professionals to learn and gain education credits. According to ...

Dialysis Centers used data from the Centers for Disease Control and Prevention to examine the prevalence of chronic diseases ...